Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG43003

CCDC25 Knockout HEK293T Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Kidney

The CCDC25 Knockout HEK293T Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population of HEK293T cells with targeted disruption of the CCDC25 gene. CCDC25 encodes a transmembrane receptor for neutrophil extracellular trap DNA (NET-DNA) that activates ILK?C??-parvin?CRac1 signaling to promote cell migration and cancer metastasis. This loss-of-function model in a widely used human embryonic kidney epithelial line enables investigation of NET-driven motility pathways. Suitable applications include dissecting CCDC25-dependent signaling via Western blotting, phospho-ILK detection, Transwell migration assays, and flow cytometry for NET-DNA binding. The polyclonal format avoids clonal artifacts, making it ideal for drug screening, pathway analysis, and anti-metastatic research.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HEK293T

    Sex of Donor

    Female

    Age

    Fetus

    Derived From Site

    Fetal kidney

    Gene Name

    CCDC25

    Gene Identifier

    NCBI Gene ID 55246

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    DMEM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The CCDC25 Knockout HEK293T Polyclonal Cells product comprises a heterogeneous population of HEK293T cells in which the CCDC25 gene has been disrupted using CRISPR/Cas9-mediated genome editing. This polyclonal knockout pool provides a loss-of-function model for studying CCDC25-dependent signaling without the need for single-cell cloning. The gene-edited cells are suitable for investigating the role of CCDC25 as a transmembrane receptor for neutrophil extracellular trap DNA (NET-DNA) and its contribution to cell migration and metastatic progression.

The parental HEK293T cell line is a widely employed human embryonic kidney epithelial cell line known for its high transfection efficiency and constitutive expression of the SV40 large T-antigen. This genetic background facilitates episomal replication of plasmids containing the SV40 origin, making HEK293T cells a preferred host for recombinant protein production, lentivirus packaging, and various functional assays. The epithelial origin and robust growth characteristics also render them a suitable model for studying cell migration and adhesion processes relevant to cancer biology.

CCDC25 encodes a transmembrane protein that functions as a receptor for NET-DNA, a component of neutrophil extracellular traps. Upon ligand binding, CCDC25 activates intracellular signaling through integrin-linked kinase (ILK) and the adaptor protein ??-parvin. This triggers downstream activation of the small GTPase Rac1, leading to actin polymerization and cytoskeletal reorganization that drives cell motility. Thus, CCDC25 acts as a critical sensor linking extracellular NET signals to the cellular migration machinery, with the ILK?C??-parvin?CRac1 axis serving as a central signaling module.

In the HEK293T background, disruption of CCDC25 abrogates the NET-DNA-induced migratory response, providing a clean system to dissect CCDC25-dependent and -independent pathways. The epithelial nature of HEK293T cells, combined with their ease of manipulation, allows for straightforward interrogation of the CCDC25?CILK?C??-parvin?CRac1 cascade. This knockout model is particularly valuable for addressing whether CCDC25 cooperates with other migratory receptors or signaling hubs endogenously expressed in kidney epithelial cells. Additionally, the polyclonal format ensures representation of diverse editing events, mitigating clonal artifacts and better reflecting population-level responses.

Researchers can employ these polyclonal knockout cells in a range of experimental workflows. Comparative Western blotting and phospho-ILK detection between wild-type and knockout cultures can reveal baseline and NET-stimulated activation states of the ILK pathway. RT-qPCR profiling enables investigation of transcriptional changes downstream of CCDC25 signaling. Transwell migration assays directly assess the requirement for CCDC25 in NET-DNA-driven cell motility, while immunofluorescence allows visualization of cytoskeletal dynamics and ??-parvin localization. Flow cytometry with labeled NET-DNA can confirm loss of receptor binding. These assays support studies aimed at elucidating NETosis-mediated metastasis, screening CCDC25 inhibitors, and evaluating anti-metastatic strategies. For additional technical details, protocols, and inquiry about custom services, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)